Although PRLR and ERBB receptors are critical regulators of normal developmental processes, such as growth and morphogenesis of mammary glands, it has become increasingly evident that their dysregulation, because of overexpression, and/or mutations, leads to the development of cancer. This evidence concerns the gene PRLR and cancer.